Difference between revisions of "Glutamate dehydrogenase"
Jump to navigation
Jump to search
(One intermediate revision by the same user not shown) | |||
Line 27: | Line 27: | ||
== Authors & References == | == Authors & References == | ||
[[NationWide Laboratories]] | [[NationWide Laboratories]] | ||
− | [[Category:Clinical Chemistry]] | + | [[Category:Clinical Chemistry|ABCDEFGHIJKLMN]] |
Latest revision as of 15:56, 28 April 2022
GLDH Introduction
Virtually liver specific, this enzyme is localised almost exclusively in the mitochondria of hepatocytes. It is generally considered that a severe insult is required to bring about its release and it is therefore not a sensitive general marker for hepatic disease. However, GLDH has been demonstrated to be a sensitive marker of hepatocellular necrosis in the dog irrespective of its severity.
Small Animals
Causes of increased GLDH activity
- Hepatocellular necrosis
- Secondary hepatopathies (for example, congestive heart failure and small intestinal pathology)
Complementary tests
ALT, albumin, bilirubin and bile acids.
Equine
GLDH has a relatively short half life in the horse (12-14 hours) compared to LDH, AST and GGT. Elevated levels therefore indicate active hepatocellular damage.
Causes of increased GLDH activity
- Hepatocellular necrosis
- Enteropathy – common and levels can be quite high
Complementary tests
AST, GGT (hepatocellular damage) and bile acids (hepatic function).